GetTopicDetailResponse(id=b8be114109d, topicName=MDI, introduction=MDI, content=null, image=null, comments=5, allHits=1155, url=https://h5.medsci.cn/topic?id=11410, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=59649, tagList=[TagDto(tagId=59649, tagName=MDI)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1985333, encodeId=c73d1985333f7, content=<a href='/topic/show?id=b8be114109d' target=_blank style='color:#2F92EE;'>#MDI#</a>, objectTitle=Nat Commun：梅楊/冀鵬團(tuán)隊(duì)揭示mDia2調(diào)控造血干祖細(xì)胞骨髓移植關(guān)鍵過(guò)程, objectType=article, longId=198330, objectId=ef4119833070, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef4119833070, replyNumber=0, likeNumber=96, createdTime=2021-03-28, rootId=0, userName=12498b08m90暫無(wú)昵稱, userId=9d0b2500136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef4119833070, moduleTitle=Nat Commun：梅楊/冀鵬團(tuán)隊(duì)揭示mDia2調(diào)控造血干祖細(xì)胞骨髓移植關(guān)鍵過(guò)程, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ef4119833070)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985331, encodeId=63a8198533114, content=<a href='/topic/show?id=b8be114109d' target=_blank style='color:#2F92EE;'>#MDI#</a>, objectTitle=Chest ：慢性阻塞性肺病患者GFF MDI聯(lián)合治療的效益與癥狀負(fù)荷之間的聯(lián)系, objectType=article, longId=106440, objectId=d10910644012, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d10910644012, replyNumber=0, likeNumber=98, createdTime=2017-10-10, rootId=0, userName=12498b08m90暫無(wú)昵稱, userId=9d0b2500136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d10910644012, moduleTitle=Chest ：慢性阻塞性肺病患者GFF MDI聯(lián)合治療的效益與癥狀負(fù)荷之間的聯(lián)系, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d10910644012)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985330, encodeId=830e1985330a2, content=<a href='/topic/show?id=b8be114109d' target=_blank style='color:#2F92EE;'>#MDI#</a>, objectTitle=Diabetes Care：2型糖尿病的血糖控制：CSII vs MDI, objectType=article, longId=99113, objectId=613d9911365, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=613d9911365, replyNumber=0, likeNumber=72, createdTime=2017-07-24, rootId=0, userName=12498b08m90暫無(wú)昵稱, userId=9d0b2500136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=613d9911365, moduleTitle=Diabetes Care：2型糖尿病的血糖控制：CSII vs MDI, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=613d9911365)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985332, encodeId=94ff19853328c, content=<a href='/topic/show?id=b8be114109d' target=_blank style='color:#2F92EE;'>#MDI#</a>, objectTitle=Respir Res：GFF MDI能否改善慢阻肺患者的24h肺功能, objectType=article, longId=114146, objectId=fff211414678, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fff211414678, replyNumber=0, likeNumber=78, createdTime=2018-04-11, rootId=0, userName=12498b08m90暫無(wú)昵稱, userId=9d0b2500136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fff211414678, moduleTitle=Respir Res：GFF MDI能否改善慢阻肺患者的24h肺功能, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=fff211414678)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1985329, encodeId=0c6e1985329aa, content=<a href='/topic/show?id=b8be114109d' target=_blank style='color:#2F92EE;'>#MDI#</a>, objectTitle=Diabetes Care：SGLT-2抑制劑Empagliflozin添加胰島素控制不佳的肥胖T2DM患者取得較好療效（EMPA-REG MDI研究）, objectType=article, longId=36771, objectId=40bf36e716f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40bf36e716f, replyNumber=0, likeNumber=92, createdTime=2014-12-08, rootId=0, userName=12498b08m90暫無(wú)昵稱, userId=9d0b2500136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40bf36e716f, moduleTitle=Diabetes Care：SGLT-2抑制劑Empagliflozin添加胰島素控制不佳的肥胖T2DM患者取得較好療效（EMPA-REG MDI研究）, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=40bf36e716f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
